TTrialPathMatch Me to Trials
← Back to trials
RecruitingRheumatoid ArthritisInterstitial Lung Disease

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

Eligible age

18–90 yrs

Accepts

All genders

Locations

4 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.

Sponsor: University of Colorado, Denver

You may qualify if…

  • ✓ Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria
  • ✓ 18 years of age or older

You may not qualify if…

  • ✕ Prior medication treatment specifically for RA-ILD
  • ✕ Inability to give informed consent
  • ✕ Pregnant women

Where it's recruiting

California

San Francisco

Colorado

Aurora

Kansas

Kansas City

Michigan

Ann Arbor

Source: ClinicalTrials.gov · NCT06397677 · last updated 2024-05-03

Defining the Molecular and Radiologic Phenotype of Progressive RA Inte · TrialPath